Cirata PLC Achieves First Positive Cash Flow Quarter in History with Strong Pipeline Growth

Cirata PLC celebrates its first-ever cash flow positive quarter, fueled by a 40% surge in pipeline value and enhanced KPI transparency.

14 April 2026by Joshua Thompson5 min read15 views

This article covers information on Cirata PLC.

LON:CRTA

Cirata Q1 FY26 trading update – first ever positive cash flow and a fatter pipeline

Cirata PLC has kicked off FY26 with something shareholders have waited years to see – a cash flow positive quarter. Management is also leaning into transparency with new KPIs that make the moving parts easier to track. The pipeline has grown by around 40% in value since January 2026, albeit with the usual enterprise-sales lumpiness.

Here is what stood out, why it matters, and what I will be watching next.

Key numbers at a glance

Metric	Q1 FY26	Comment
Closing ACV	$4.9m	Up from $4.8m at 31 Dec 2025
Net new ACV	$0.1m	From existing customers – no new logo ACV booked
ACV expired	Nil	No contract roll off in the period
Billings	$2.3m	Invoices issued in the quarter
RCB	$5.8m	Remaining contracted billings not yet invoiced
RCB due < 12 months	$3.4m	Near-term visibility
Quarterly cash flow	$0.7m	First positive cash flow quarter in company history
Cash at 31 Mar 2026	$4.7m	Unaudited
Short-term trade receivables	$0.7m	Due within 90 days
Cash + short-term receivables	$5.4m	Liquidity snapshot
Cash overheads	$3.1m in Q1	FY26 target range $12-13m

Why the new KPIs matter – ACV, Billings and RCB explained

Cirata is now reporting three operational KPIs that improve visibility:

ACV – annualised contract value. This is the annualised value of live customer contracts at a point in time and is independent of revenue recognition and invoice timing.
Billings – the value of invoices issued during the period. This is a cleaner cash proxy than reported revenue.
RCB – remaining contract billings not yet invoiced. Think of it as the near-term backlog of contracted cash flows.

In Q1 FY26, ACV ticked up to $4.9m with no expiries, which is solid if unspectacular. Billings of $2.3m show the company’s ability to turn contracts into invoices. RCB of $5.8m – with $3.4m due inside 12 months – offers forward visibility that should help investors gauge momentum between quarters.

Commercial momentum and pipeline quality

Management says the pipeline expanded by around 40% in value since January 2026, spanning both new logos and expansions within existing accounts. That is a meaningful step-up and follows a record FY25 in which the company delivered its strongest Data Integration bookings since 2017 and achieved positive EBITDA in H2 FY25 for the first time.

There is a nuance here: net new ACV in the quarter was $0.1m and all from existing customers, with no new logo ACV recorded. That can happen in enterprise sales where large deals are lumpy and take time to close. The absence of expiries helps the base, and the enlarged pipeline is the real lead indicator – the key will be conversion in the next few quarters.

Share𝕏 in

Investing
Polar Capital Technology Trust Reports 102% NAV Growth in Stellar Fiscal Year
Polar Capital Technology Trust sees 102% NAV growth in FY2026, beating its benchmark by 47 points thanks to AI and semiconductor exposure.
JoshuaJuly 10, 2026
Investing

Tagged

Last updated

5 July 2026

Star Rating

No ratings yet

Cirata Symphony and enterprise use cases pushing demand

Cirata is leaning on its Customer Innovation Board to align product focus with specific, budgeted use cases. Cirata Symphony targets areas like:

Petabyte-scale data migration and replication
Disaster recovery – where outages can cost circa $6,000 per minute, and Symphony aims to restore in minutes rather than hours or days
Data modernisation to support AI-driven initiatives

This is classic enterprise software positioning – solve high-stakes, high-value problems with repeatable solutions that scale. The company notes it has now managed over 300 petabytes of data across demanding environments, and it continues to progress its OEM relationship with IBM alongside direct and partner-led sales.

Cash, overheads and the FY26 outlook

Cash generation is the headline: $0.7m positive cash flow in Q1 FY26. Cash closed at $4.7m with a further $0.7m in short-term receivables, taking the cash-plus-receivables balance to $5.4m. Cash overheads were $3.1m in the quarter, consistent with the FY26 annualised target of $12-13m and down more than 70% from peak, according to management.

The outlook is unchanged. Cirata continues to target cash flow break even for FY26 and expects visibility to improve by mid-year. Management reiterates that enterprise sales are inherently lumpy, which investors should take at face value – the pipeline has grown, but conversion timing will dictate the quarterly rhythm.

My take – what’s good, what’s not, and what I’m watching

Positives worth noting

First ever cash flow positive quarter – a credibility boost after FY25’s turning point.
RCB of $5.8m, with $3.4m due within 12 months – tangible forward visibility.
No contract expiries in the quarter – retention underpinning the base.
Pipeline up circa 40% since January 2026 – a strong demand signal.
Clearer KPI reporting – ACV, Billings, RCB should reduce guesswork between results.

Watch-outs and open questions

New logo ACV was nil in Q1 – conversion from the enlarged pipeline needs to show up in signed new customers.
Net new ACV of $0.1m is modest – the step-change likely sits in the pipeline, not yet on the books.
Enterprise cycles remain extended – management flags lumpiness, so quarters may vary even if the annual trend is up.

What I will track next

New logo wins and their ACV contribution – the cleanest proof of broader market traction.
ACV growth rate relative to Billings – to see whether the contracted base is compounding faster than it is being monetised.
RCB mix due within 12 months – changes here fine-tune cash visibility.
Progress in the IBM OEM channel and Symphony deployments – both could accelerate scale if deals land.
Consistency of cash generation as overheads hold within the $12-13m target range.

Bottom line for shareholders

Cirata has backed up last year’s operational reset with a cash-positive quarter, a larger pipeline, and clearer metrics. The quarter itself was steady rather than spectacular on new contracts, but the ingredients for a stronger FY26 are visible – expanded sales coverage, larger enterprise opportunities, and product focus on urgent, budgeted use cases.

If pipeline conversion comes through and RCB continues to build, the path to full-year cash flow break even looks credible. The next couple of quarters will be about execution – turning that 40% pipeline growth into signed ACV, not just conversations.